Controlled Release Drug Delivery Market Overview, Growth, and Trends (2021-2031)

MARKET INTRODUCTION

Controlled release drug delivery systems are used by physicians in order to allow reduced amount of dose and dosage frequency, enhanced less fluctuation in plasma drug levels, uniform drug effect, patient compliance and acceptance. Wurster coating is the one of the oldest technology being used for controlled release of drug since 1976. There are few new controlled-release drug delivery technologies are expected to be in commercialization phase in next few years. For instance, MicroCor PTH using MicroCor transdermal technology, in phase IIa. Oral controlled drug delivery systems are generally helpful for elderly and pediatric population. Commercially available medications using controlled-release drug delivery technology include Avinza (polymer coating), Alza (osmotically activated system), Capoten (enzyme activated system), GLUCOPHAGE XR (polymer matrix based system), Prozac (polymer matrix based system), etc.

MARKET DYNAMICS

The rising geriatric population, rising investments from pharmaceutical and biopharmaceutical companies in research and development to design advanced drug delivery systems, rising healthcare expenditure and rising number of premature births are few major factors driving the controlled release drug delivery market. However there are few factors that may affect the controlled release drug delivery market negatively which include high dose of API requirement and controlled drug release systems are expensive in nature as compared to traditional pharmaceutical formulations.

MARKET SCOPE

The "Global Controlled Release Drug Delivery Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of controlled release drug delivery market with detailed market segmentation by technology, release mechanism, application and geography. The global controlled release drug delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading controlled release drug delivery market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global controlled release drug delivery market is segmented on the basis of technology, release mechanism and application. Based on technology, the market is segmented as Wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others. On the basis of release mechanism, the global controlled release drug delivery market is segmented into activation modulated, micro reservoir feedback regulated, partition controlled, polymer matrix systems, and chemically activated systems. Based on application, the market is segmented into injectables, drug eluting stents, oral controlled, transdermal and ocular patches, infusion pumps, and metered dose inhalers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global controlled release drug delivery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The controlled release drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting controlled release drug delivery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the controlled release drug delivery market in these regions.

MARKET PLAYERS

The reports cover key developments in the controlled release drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from controlled release drug delivery market are anticipated to lucrative growth opportunities in the future with the rising demand for controlled release drug delivery in the global market. Below mentioned is the list of few companies engaged in the controlled release drug delivery market.

The report also includes the profiles of key controlled release drug delivery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Orbis Biosciences, Inc.
• Merck and Co., Inc.
• Alkermes Plc.
• Johnson and Johnson
• Coating Place, Inc.
• Corium International, Inc.
• Depomed, Inc.
• Pfizer, Inc.
• Aradigm Corporation
• Capsugel

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Controlled Release Drug Delivery Report Scope